Valuation: BOIRON

Market Cap 477M 546M 438M 409M 775M 52B 787M 5.27B 2.05B 25.55B 2.05B 2.01B 88.12B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 430M 491M 394M 368M 697M 46.79B 708M 4.74B 1.84B 22.99B 1.84B 1.8B 79.29B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-0.36%
1 week-2.48%
Current month-0.72%
1 month+1.48%
3 months-1.79%
6 months-8.64%
Current year-9.24%
1 week 27.5
Extreme 27.5
28.1
1 month 27.1
Extreme 27.1
29
Current year 24.35
Extreme 24.35
30.95
1 year 20.85
Extreme 20.85
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Date Insider Type Main position Quantity % Market Cap.
23-10-28Sell 858,660 4.8939%
23-10-28Sell

Director

3,267,121 18.6209%
23-10-28Sell

Director

3,267,121 18.6209%
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-2.48%+22.49%-30.38% 546M
+0.21%+3.96%-12.47%-7.71% 12.84B
+0.34%+4.33%-34.57%-57.93% 4.72B
+2.23%+12.59%+17.91%-6.37% 3.91B
+1.10%+6.55%+4.13%-39.43% 3.84B
+0.13%-11.54%-14.01%-20.23% 3.05B
+1.74%+5.74%-11.17%-1.48% 3.08B
+0.79%+6.47%-7.22%-25.40% 2.38B
+0.53%+7.02%-14.09%+33.06% 1.72B
+2.59%+8.49%-11.64%-14.77% 1.69B
Average +0.93%-0.03%-6.06%-17.06% 3.78B
Weighted average by Cap. +0.79%+0.10%-9.61%-17.48%

Financials

2024 2025
Net sales 488M 557M 448M 418M 791M 53.1B 803M 5.38B 2.09B 26.09B 2.09B 2.05B 89.98B 501M 573M 460M 429M 813M 54.57B 825M 5.53B 2.15B 26.81B 2.15B 2.1B 92.48B
Net income 11.34M 12.96M 10.41M 9.71M 18.4M 1.23B 18.67M 125M 48.6M 607M 48.66M 47.6M 2.09B 32.64M 37.32M 29.98M 27.96M 52.99M 3.55B 53.77M 360M 140M 1.75B 140M 137M 6.02B
Net Debt -49.74M -56.87M -45.67M -42.61M -80.74M -5.42B -81.93M -549M -213M -2.66B -214M -209M -9.18B -47.86M -54.72M -43.94M -40.99M -77.68M -5.21B -78.83M -528M -205M -2.56B -205M -201M -8.83B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume
26-07-03 €27.50 -0.36% 2,276
26-07-02 €27.60 0.00% 827
26-07-01 €27.60 -0.36% 772
26-06-30 €27.70 -1.07% 930
26-06-29 €28.00 -0.71% 529

Annual profits - Rate of surprise